Expert Guidance: Physician Growth Partners Facilitates Successful Transaction Between Zimm Cataract Laser Center and Sunvera Group

Physician Growth Partners Advises Zimm Cataract & Laser Center on Transaction How a Recent Partnership is Shaping the Eyecare Industry Physician Growth Partners (PGP) has recently guided Zimm Cataract & Laser Center through a strategic partnership with Sunvera Group, a leading eyecare platform backed by Ridgemont Equity Partners. The collaboration, which also involves Premier Surgical…

Read More

Calling All Amarin Shareholders: Let’s Talk About Sarissa’s Special Meeting Notice!

Amarin Responds to Sarissa’s Request for Special Meeting Significant Board Refreshment, Operational, and Financial Improvements DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 11, 2023 (GLOBE NEWSWIRE) — Amarin Corporation plc has officially acknowledged the receipt of a request from Sarissa Capital Management LP to convene a General Meeting of Shareholders. This request, also known as the…

Read More

Revolutionizing Recycling: Ozop Energy Solutions Inc. and Cirba Solutions Team Up for National EV Battery Dealership Program

Revolutionizing Recycling: Ozop Energy Solutions Inc. and Cirba Solutions Team Up for National EV Battery Dealership Program Introduction Warwick, NY, Jan. 11, 2023 (GLOBE NEWSWIRE) — Ozop Energy Solutions, Inc. (OZSC or the “Company”). Ozop Energy Solutions Inc. (“OZOP”) has signed a multi-year contract with Cirba Solutions, the leading provider of battery management and materials…

Read More

DoubleDown Interactive Secures Acquisition of iGaming Operator Suprnation through Share Purchase Agreement: A Strategic Move for Business Success

DoubleDown Interactive Enters into Share Purchase Agreement to Acquire i-Gaming Operator, SuprNation SEATTLE, Jan. 11, 2023 (GLOBE NEWSWIRE) — DoubleDown Interactive Co., Ltd. (NASDAQ: DDI) (“DoubleDown” or the “Company”), a leading gaming company, delivering unique player experiences across a variety of genres, today announced that the Company has entered into a Share Purchase Agreement (the…

Read More

Breaking News: Eton Pharmaceuticals Receives FDA Approval for Dehydrated Alcohol Injection NDA Response – What This Means for the Medical Industry

Eton Pharmaceuticals Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection DEER PARK, Ill., Jan. 11, 2023 (GLOBE NEWSWIRE) — Eton Pharmaceuticals Product previously granted orphan drug designation for methanol poisoning Eton Pharmaceuticals (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced…

Read More